ERDERA Learning Portal
The ERDERA Learning Portal brings together courses and resources for researchers, clinicians, patient representatives, policymakers, and industry professionals, suited to different levels of knowledge. Some of the training and resources presented are developed or endorsed by ERDERA, while others are provided by external organisations and are not ERDERA training. By supporting skills development, encouraging collaboration, and facilitating knowledge exchange, ERDERA helps connect people and expertise across the rare disease research community.
TYPE
LEVEL
STATUS
LENGTH
COST
CERTIFICATION
CATEGORY
TAG CLOUD
Contact the Training & Education Work Stream. Please note that you will leave the ERDERA environment
Open Academy x ERDERA Training on Data, Ethics and AI
- 2027 | AI technologies | Data Collection and Sharing | Data Stewardship | Early Career Researchers | ERDERA | Ethics | EURORDIS–Rare Diseases Europe | Open Academy | Patient Advocacy | Regulatory
Open Academy x ERDERA School on Medicines Research and Development
- 2027 | Data Stewardship | ERDERA | EURORDIS–Rare Diseases Europe | Medicines Research and Development | Open Academy
Open Academy x ERDERA School on Scientific Innovation & Translational Research
- 2027 | ERDERA | EURORDIS–Rare Diseases Europe | Innovation | Open Academy | Translational Research
Closed training
Materials available
Situating Ethics in the Research Continuum | ERDERA Ethics & Regulatory Webinar Series
- AI technologies | ATMPs (Advanced Therapy Medicinal Products) | Ethics
Closed training
Materials available
ERDERA diagnostic research workstream webinar series – An overview (session 1)
- Diagnostics | Genomics | Multi-omics
Closed training
Materials available
Enhancing Patient-Centricity in Rare Disease Clinical Trials
- Clinical Trials | Patient Advocacy | Patient engagement | Patient Public Involvement and Engagement (PPIE) | Ultra-rare diseases
Closed training
Materials available
Single arm, RCT or something in between – how to enrich clinical trial design and analysis in rare diseases
- Clinical Trials | Health Technology Assessment (HTA) | Real World Evidence | Real-World Data (RWD) | Regulatory | Single‑Arm Trials (SATs) | Ultra-rare diseases
Closed training
Materials available
Evidence Assessment Framework. The need for a mindset shift among developers, regulators and HTAs
- Clinical Trials | Health Technology Assessment (HTA) | Real World Evidence | Regulatory